J Exp Clin Cancer Res
J Exp Clin Cancer Res
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
2067
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 2067 PapersABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan…
Bergonzini C, Gregori A, Hagens TMS, van der Noord VE, van de Water B, Zweemer AJM, Coban B, Capula…
A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion accordi…
Bartolomé RA, Pintado-Berninches L, Martín-Regalado Á, Robles J, Calvo-López T, Ortega-Zapero M, Ll…
A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.
Feng C, Yu A, Wang Z, Wang K, Chen J, Wu Y, Deng T, Chen H, Hou Y, Ma S, Dai X, Huang L.
A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimenti…
Zhang Y, Liu Z, Zhong Z, Ji Y, Guo H, Wang W, Chen C.
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy.
Meraz-Torres F, Niessner H, Plöger S, Riel S, Schörg B, Casadei N, Kneilling M, Schaller M, Flatz L…
Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators…
Stitzlein LM, Adams JT, Stitzlein EN, Dudley RW, Chandra J.
DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
Wei S, Xing J, Chen J, Chen L, Lv J, Chen X, Li T, Yu T, Wang H, Wang K, Yu W.
EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL.
Pan M, Luo M, Liu L, Chen Y, Cheng Z, Wang K, Huang L, Tang N, Qiu J, Huang A, Xia J.
EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
Wei W, Liu K, Huang X, Tian S, Wang H, Zhang C, Ye J, Dong Y, An Z, Ma X, Wang B, Huang Y, Zhang X.
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.
Cappelletto A, Alfì E, Volf N, Vu TVA, Bortolotti F, Ciucci G, Vodret S, Fantuz M, Perin M, Colliva…